Roche received U.S. FDA approval for an Alzheimer's disease blood test. "Roche Gets FDA Clearance Alzheimer's Disease Drug" and "Roche: Drug Developed in Collaboration With Eli Lilly" at 1116 GMT and 1117 GMT incorrectly said the approval was for a drug.

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer's disease assessment across primary and specialty care